Literature DB >> 14993453

The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.

Robert Hnasko1, Michael P Lisanti.   

Abstract

Caveolae, plasma membrane invaginations that serve as membrane organizing centers, are found in most cell types, but are enriched in adipocytes, endothelial cells, and myocytes. Three members of the caveolin family (Cav-1, -2, and -3) are essential for the formation of caveolae. Specialized motifs in the caveolin proteins function to recruit lipids and proteins to caveolae for participation in intracellular trafficking of cellular components and operation in signal transduction. Mutations in the gene encoding CAV-1 are associated with the development and progression of breast cancers, whereas mutations in the CAV-3 gene result in Rippling Muscle Disease and a form of Limb-Girdle Muscular Dystrophy. The generation of caveolin-null mice has confirmed the essential role of these proteins in caveolae biogenesis and in the pathophysiology of diverse tissues. Caveolin-null mice provide new animal models for studying the pathogenesis of a number of human diseases, including cancer, diabetes, atherosclerosis, restrictive lung disease and pulmonary fibrosis, cardiomyopathy, muscular dystrophy, and bladder dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14993453     DOI: 10.1124/mi.3.8.445

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  76 in total

Review 1.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

2.  Diabetes-related alterations in the enteric nervous system and its microenvironment.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Diabetes       Date:  2012-05-15

3.  Do studies in caveolin-knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for 'lost proteins'?

Authors:  P A Insel; H H Patel
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

4.  Quis custodiet ipsos custodies: who watches the watchmen?

Authors:  Cyrus M Ghajar; Roland Meier; Mina J Bissell
Journal:  Am J Pathol       Date:  2009-06       Impact factor: 4.307

5.  Abnormal bradykinin signalling in fibroblasts deficient in the PIP(2) 5-phosphatase, ocrl1.

Authors:  S F Suchy; J C Cronin; R L Nussbaum
Journal:  J Inherit Metab Dis       Date:  2009-01-28       Impact factor: 4.982

6.  Caveolin-1 (CAV-1) up regulation in metabolic syndrome: all roads leading to the same end.

Authors:  Gabriela Montenegro de Souza; Maria Eduarda de Albuquerque Borborema; Thays Maria Costa de Lucena; Ariane Fernandes da Silva Santos; Brenda Regina de Lima; Dinaldo Cavalcanti de Oliveira; Jaqueline de Azevêdo Silva
Journal:  Mol Biol Rep       Date:  2020-10-29       Impact factor: 2.316

7.  Caveolae-dependent internalization and homologous desensitization of VIP/PACAP receptor, VPAC₂, in gastrointestinal smooth muscle.

Authors:  Sunila Mahavadi; Sayak Bhattacharya; Jennnifer Kim; Sally Fayed; Othman Al-Shboul; John R Grider; Karnam S Murthy
Journal:  Peptides       Date:  2013-03-15       Impact factor: 3.750

8.  Contractions but not AICAR increase FABPpm content in rat muscle sarcolemma.

Authors:  Jacob Jeppesen; Peter Albers; Joost J Luiken; Jan F C Glatz; Bente Kiens
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

9.  Involvement of caveolin-1 in neurovascular unit remodeling after stroke: Effects on neovascularization and astrogliosis.

Authors:  Camille Blochet; Lara Buscemi; Tifenn Clément; Sabrina Gehri; Jérôme Badaut; Lorenz Hirt
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-24       Impact factor: 6.200

10.  Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Authors:  Caterina Bianco; Luigi Strizzi; Mario Mancino; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Ahmed Raafat; Lawson Sahlah; Cindy Chang; Federica Sotgia; Nicola Normanno; Michael Lisanti; David S Salomon
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.